Ophthalmology Innovation Summit @ AAO 2013 - November 14th - New Orleans
The purpose of OIS is to create an ecosystem of clinical, technology and business. Uniting this diverse group of key players in the ophthalmic field fosters innovation and facilitates business transactions. The conference provides a forum for addressing key issues impacting the ophthalmic field and a platform to showcase the most promising private ophthalmic companies. Be among 700+ Innovators/Entrepreneurs, Clinicians, Venture Capitalists, Senior R&D and Biz Dev Execs from Private and Public Companies.
Summit Chairman
Emmett Cunningham, Jr., MD, PhD, MPH
Partner
Clarus Ventures, LLC
Summit Co-Chairs
Gilbert Kliman, MD
Managing Director
InterWest Partners
William Link, PhD
Managing Director
Versant Ventures
Why Attend OIS?
Simple: Meet the most important people in the ophthalmic business.
Hotel / Venue
Sheraton New Orleans OIS has a reduced room rate of $269 at the Marriott.
New Orleans, Louisiana
Keynote Speakers
David E.I. Pyott Chairman of the Board,
President & Chief Executive Officer
Allergan, Inc.
Agenda Highlights
Coming Soon…Get Notified When Agenda is Confirmed→
Past Ophthalmology Conference Video Clip
What People Are Saying About OIS @ AAO
"OIS is a unique meeting because it brings together clinical investigators, physician thought leaders, venture capitalists, and executives of both large and small start up companies - all sharing the collective goal of bringing innovative and vision enhancing technologies to market. The format offers a nice mix of executive summary presentations and interactive panel discussion".
David F. Chang MDPresident, ASCRS
"Presenting RVO's technology at OIS has attracted a lot of interest from investors, clinicians, and strategic companies. Everyone leaves OIS with a better vision of the future of the ophthalmic industry."
Randy AlexanderChairman, ReVision Optics
"OIS gives industry a forum to interact in a meaningful way with clinicians and private companies which results in excellent synergy. I came away with a deeper understanding of how industry can help."
Joseph Markoff MD PhDGlobal Director for Scientific Affairs in Ophthalmology, Merck Inc.
"OIS is the merger of ophthalmic ideas and money. I recommend it to everyone."
Andy CorleyYelroc Consulting
"The OIS meeting provides a unique opportunity for business professionals and clinician/scientists to share a robust meeting program regarding innovation and commercialization and to develop the relationships necessary for success. The AAO is proud that OIS meets in conjunction with us."
David W. Parke II, MDExecutive Vice President & CEO, American Academy of Ophthalmology
